Advertisement

Payer

Advertisement

Bloomfield, Conn.-based Cigna dropped coverage for Mylan's EpiPen and EpiPen Jr. auto-injectors in favor of its generic alternative according to the payer's prescription drug list changes, which were effective Jan. 7. 

Four of the nation's largest health insurers are entrenched in antitrust trials over concerns their proposed consolidations will impede competition. And with such insurer mergers, market concentration plays a key role when insurers and providers bargain over commercial healthcare prices,…

Advertisement